{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T05:40:09Z","timestamp":1734673209811,"version":"3.32.0"},"reference-count":17,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Haemophilia"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Acquired von Willebrand syndrome (AVWS) is a rare haemorrhagic disorder. The prophylaxis and treatment of bleeding before surgery are complex. Since 2018, a new recombinant VWF (rVWF) concentrate that contains no factor VIII (FVIII) but a high amount of high molecular weight VWF multimers has been available in France.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To describe the real\u2010world experience of using rVWF in non\u2010surgical bleeding and surgical procedures in patients with AVWS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Fifteen bleeding episodes in seven patients and 16 surgeries in 10 patients were retrospectively analysed in t French haemostasis centres.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>During bleeding, the median number of infusions was only 1 (range 1\u201327) with a median loading dose of 58\u00a0IU\/kg (range 17\u2013116) rVWF and a total median dose of 65\u00a0IU\/kg (range 35\u20131488) rVWF. Bleeding control was rated markedly effective in 73% (11\/15) of the cases and ineffective in 27% (4\/15).<\/jats:p><jats:p>During surgeries, the median number of infusions was 3 (range 1\u20138) with a preoperative loading dose of 60\u00a0IU\/kg (range 23\u2013118) rVWF and a total median dose of 123\u00a0IU\/kg (range 31\u2013542). The overall clinical efficacy was qualified as excellent, good and poor (ISTH criteria) in respectively 7 (43%), 6 (38%) and 3 (19%) procedures.<\/jats:p><jats:p>There was no accumulation of VWF or FVIII during postoperative monitoring. No thromboembolic events nor adverse events were reported.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This French \u2018real\u2010world\u2019 experience shows that rVWF could be of interest in the treatment and prophylaxis of bleeding in patients with AVWS, with no clinically significant safety concern.<\/jats:p><\/jats:sec>","DOI":"10.1111\/hae.15098","type":"journal-article","created":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T11:13:43Z","timestamp":1727522023000},"page":"1341-1347","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of a recombinant von Willebrand factor treatment in acquired von Willebrand syndrome in case of bleeding and surgical procedures"],"prefix":"10.1111","volume":"30","author":[{"given":"Dominique","family":"Desprez","sequence":"first","affiliation":[{"name":"Haemophilia Treatment Centre University Hospital of Strasbourg  Strasbourg France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e9a","family":"Pierre","sequence":"additional","affiliation":[{"name":"Haemophilia Treatment Centre University Hospital of Strasbourg  Strasbourg France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Hittinger","sequence":"additional","affiliation":[{"name":"Haemophilia Treatment Centre University Hospital of Nantes  Nantes France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9284-7094","authenticated-orcid":false,"given":"Antoine","family":"Babuty","sequence":"additional","affiliation":[{"name":"Haemophilia Treatment Centre University Hospital of Nantes  Nantes France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2702-6246","authenticated-orcid":false,"given":"Laurent","family":"Sattler","sequence":"additional","affiliation":[{"name":"Haemophilia Treatment Centre University Hospital of Strasbourg  Strasbourg France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Ternisien","sequence":"additional","affiliation":[{"name":"Haemophilia Treatment Centre University Hospital of Nantes  Nantes France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1040-0086","authenticated-orcid":false,"given":"Agathe","family":"Herb","sequence":"additional","affiliation":[{"name":"Haemophilia Treatment Centre University Hospital of Strasbourg  Strasbourg France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4072-839X","authenticated-orcid":false,"given":"Marc","family":"Trossa\u00ebrt","sequence":"additional","affiliation":[{"name":"Haemophilia Treatment Centre University Hospital of Nantes  Nantes France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne\u2010C\u00e9cile","family":"G\u00e9rout","sequence":"additional","affiliation":[{"name":"Haemophilia Treatment Centre University Hospital of Strasbourg  Strasbourg France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0964-0739","authenticated-orcid":false,"given":"Marc","family":"Fouassier","sequence":"additional","affiliation":[{"name":"Haemophilia Treatment Centre University Hospital of Nantes  Nantes France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan","family":"Wimmer","sequence":"additional","affiliation":[{"name":"Haemophilia Treatment Centre University Hospital of Strasbourg  Strasbourg France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Feugeas","sequence":"additional","affiliation":[{"name":"Haemophilia Treatment Centre University Hospital of Strasbourg  Strasbourg France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6500-5190","authenticated-orcid":false,"given":"Nicolas","family":"Drillaud","sequence":"additional","affiliation":[{"name":"Haemophilia Treatment Centre University Hospital of Nantes  Nantes France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,9,28]]},"reference":[{"issue":"2","key":"e_1_2_11_2_1","first-page":"345","article-title":"Acquired von Willebrand syndrome: data from an international registry","volume":"84","author":"Federici AB","year":"2000","journal-title":"J Thromb Haemost"},{"key":"e_1_2_11_3_1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2022.08.025","article-title":"Acquired von Willebrand syndrome: five cases report and literature review","volume":"218","author":"Ghariani I","year":"2022","journal-title":"Thromb Res"},{"issue":"8","key":"e_1_2_11_4_1","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.3324\/haematol.2020.255117","article-title":"Acquired von Willebrand syndrome: focused for hematologists","volume":"105","author":"Franchini M","year":"2020","journal-title":"Haematologica"},{"issue":"2","key":"e_1_2_11_5_1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1600-0609.2011.01636.x","article-title":"Pathophysiology of acquired von Willebrand disease: a concise review","volume":"87","author":"Shetty S","year":"2011","journal-title":"Eur J Haematol"},{"issue":"6","key":"e_1_2_11_6_1","first-page":"1337","article-title":"Acquired von Willebrand syndrome","volume":"25","author":"Mital A","year":"2016","journal-title":"Clin Exp Med"},{"issue":"6","key":"e_1_2_11_7_1","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.transci.2018.10.012","article-title":"Management of acquired von Willebrand syndrome","volume":"57","author":"Charlebois J","year":"2018","journal-title":"Transfus Apher Sci"},{"issue":"6","key":"e_1_2_11_8_1","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1586\/17474086.2015.1060854","article-title":"Treatment of the acquired von Willebrand syndrome","volume":"8","author":"Budde U","year":"2015","journal-title":"Expert Rev Hematol"},{"key":"e_1_2_11_9_1","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1182\/blood-2013-01-479527","article-title":"Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma\u2010free method: a prospective clinical trial","volume":"122","author":"Mannucci PM","year":"2013","journal-title":"Blood"},{"key":"e_1_2_11_10_1","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood-2015-02-629873","article-title":"Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease","volume":"126","author":"Gill JC","year":"2015","journal-title":"Blood"},{"key":"e_1_2_11_11_1","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/jth.14313","article-title":"Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery","volume":"17","author":"Peyvandi F","year":"2019","journal-title":"J Thromb Haemost"},{"issue":"2","key":"e_1_2_11_12_1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/hae.14242","article-title":"Efficacy and safety of a recombinant von Willebrand factor treatment in patients with inherited von Willebrand disease requiring surgical procedures","volume":"27","author":"Desprez D","year":"2021","journal-title":"Haemophilia"},{"issue":"1","key":"e_1_2_11_13_1","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1055\/a-2008-4367","article-title":"Treatment of acquired von willebrand disease due to extracorporeal membrane oxygenation in a pediatric COVID\u201019 patient with vonicog alfa: a case report and literature review","volume":"7","author":"Heubner L","year":"2023","journal-title":"TH Open"},{"key":"e_1_2_11_14_1","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s11239-019-02018-1","article-title":"Vonicog alfa for the management of von Willebrand disease: a comprehensive review and single\u2010center experience","volume":"49","author":"Tran T","year":"2020","journal-title":"J Thromb Thrombolysis"},{"key":"e_1_2_11_15_1","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1177\/1076029617715117","article-title":"Major and minor classifications for surgery in people with hemophilia: a literature review","volume":"24","author":"Solimeno LP","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"issue":"25","key":"e_1_2_11_16_1","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1182\/blood-2010-11-297580","article-title":"How I treat the acquired von Willebrand syndrome","volume":"117","author":"Tiede A","year":"2011","journal-title":"Blood"},{"issue":"3","key":"e_1_2_11_17_1","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1111\/hae.13436","article-title":"Advantage of recombinant von Willebrand factor for peri\u2010operative management in paediatric acquired von Willebrand syndrome","volume":"24","author":"Weyand AC","year":"2018","journal-title":"Haemophilia"},{"issue":"4","key":"e_1_2_11_18_1","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1053\/j.jvca.2022.12.028","article-title":"In vitro treatment of extracorporeal membrane oxygenation coagulopathy with recombinant von Willebrand factor or lyophilized platelets","volume":"37","author":"Mazzeffi M","year":"2023","journal-title":"J Cardiothorac Vasc Anesth"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hae.15098","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T05:00:06Z","timestamp":1734670806000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hae.15098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,28]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1111\/hae.15098"],"URL":"https:\/\/doi.org\/10.1111\/hae.15098","archive":["Portico"],"relation":{},"ISSN":["1351-8216","1365-2516"],"issn-type":[{"type":"print","value":"1351-8216"},{"type":"electronic","value":"1365-2516"}],"subject":[],"published":{"date-parts":[[2024,9,28]]},"assertion":[{"value":"2024-07-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}